Dr Marco Gerlinger on working with pharmaceutical companies

I’m Marco Gerling I’m leading the translation alone continuous group in the Center for evolution cancer at the Institute of cancer research we’re working closely with pharma companies first of all to trial their novel drugs in our patients and at the same time look through detailed molecular analysis into how drug resistance evolves to these novel agents and how we can reverse or prevent that in the future in addition we’re working with diagnostic companies to develop the relevant tests – first of all decipher drug resistance mechanisms but also to make clinical decisions more rationally about treatments which is and how to control drug resistance or reverse drug resistance

Leave a Reply

(*) Required, Your email will not be published